<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04192760</url>
  </required_header>
  <id_info>
    <org_study_id>UHZ Bad Krozingen-cathlab</org_study_id>
    <nct_id>NCT04192760</nct_id>
  </id_info>
  <brief_title>Culotte Versus DK-CRUSH Technique in Non-left Main Coronary Bifurcation Lesions</brief_title>
  <acronym>BBK-3</acronym>
  <official_title>Bifurcations Bad Krozingen (BBK) 3 - Trial Randomised Comparison of Culotte-stenting Versus DK-Crush--stenting for the Treatment of de Novo Non-left Main Coronary Bifurcation Lesions With Everolimus-eluting Stents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Heart Center Freiburg - Bad Krozingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Heart Center Freiburg - Bad Krozingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomised comparison of Culotte technique versus &quot;Double Kissing&quot; - Crush technique
      (DK-Crush) for the percutaneous treatment of de novo non-left main coronary bifurcation
      lesions with modern everolimus-eluting stents (DES) - European multicenter study
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim of study This prospective randomized multicenter study will compare the long-term safety
      and efficacy of Culotte stenting versus &quot;Double Kissing&quot; - Crush (DK-Crush) stenting in the
      treatment of the de-novo non-left main coronary bifurcation lesions with new generation
      everolimus-eluting stents.

      Study hypothesis In large coronary bifurcation lesions (main vessel ≥2.5mm, side branch
      ≥2.25mm) including significant ostial side branch disease, Culotte stenting compared with
      DKcrush stenting reduces maximal percent diameter stenosis at the bifurcation at 9-month
      follow-up by 25 %, relative.

      Study design Prospective, randomized, European multicenter study.

      Methods Four-hundred patients, in whom a double-stenting technique is intended for the
      treatment of a non-left main de-novo coronary bifurcation lesion will be randomly assigned to
      Culotte stenting or to DK-crush stenting with an approved drug-eluting stent (SYNERGY-Stent).
      As a part of usual care, patients will undergo 9-month angiographic follow-up with
      quantitative coronary angiography. Clinical follow-up is planned at 30 days, 6 months, 1 year
      and 2 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Angiographic restenosis in the bifurcation lesion by quantitative coronary analysis (QCA)</measure>
    <time_frame>9 months post index percutaneous coronary intervention (PCI)</time_frame>
    <description>For quantitative coronary angiography, changes between result at the completion of the index intervention and at 9 months follow-up will be analysed using a computer based system dedicated to bifurcation analysis, according to the standard operating procedure of the angiographic core laboratory.
Quantitative angiographic measurements will be obtained of the three segments of the bifurcation lesion: the proximal and distal segment of the main branch and the side branch. We will perform measurements in the stented portion of the vessel (in-stent) and in the distal or proximal 5 mm margin (edge). In-segment analyses will comprise the in-stent and the edge area.
In addition, the bifurcation angle from the analysis system will be estimated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of target lesion revascularisation (TLR)</measure>
    <time_frame>30 days, 6 months, 1 year, 2 years</time_frame>
    <description>Any revascularisation (Re-PCI or CABG) at segments treated during index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of major adverse cardiac events (MACE)</measure>
    <time_frame>30 days, 6 months, 1 year, 2 years</time_frame>
    <description>MACE defined as death, Myocardial infarction (Q wave and Non-Q wave), emergent cardiac bypass surgery, or TLR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of binary restenosis at any segment of the bifurcation</measure>
    <time_frame>9 months</time_frame>
    <description>≥ 50% diameter stenosis in the main and side branch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of binary restenosis in the main and side branch</measure>
    <time_frame>9 months</time_frame>
    <description>≥ 50% diameter stenosis in main and side branch</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of stent thrombosis (ST)</measure>
    <time_frame>1 year, 2 year</time_frame>
    <description>Post-procedure thrombotic stent occlusion according to the Academic Research Consortium-criteria</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Rate of device success</measure>
    <time_frame>9 months</time_frame>
    <description>Attainment of &lt; 30% residual stenosis of the target lesion in the main and side branch</description>
  </other_outcome>
  <other_outcome>
    <measure>Mean procedure time</measure>
    <time_frame>Index Intervention</time_frame>
    <description>Procedure time measured in minutes</description>
  </other_outcome>
  <other_outcome>
    <measure>Mean radiation exposure</measure>
    <time_frame>Index Intervention</time_frame>
    <description>Radiation exposure measured in mGym²</description>
  </other_outcome>
  <other_outcome>
    <measure>Mean volume of used contrast medium</measure>
    <time_frame>Index Intervention</time_frame>
    <description>Contrast medium measured in milliliters</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Coronary Stenosis</condition>
  <condition>Stent Stenosis</condition>
  <arm_group>
    <arm_group_label>Culotte Technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Both vessels have to be wired. Lesion preparation in the main vessel and side branch may be undertaken according to operator preference. After lesion preparation, the side branch has to be stented first.
The first stent is placed from main branch into the side branch side branch, covering the entire diseased segment with a wire jailed in the main vessel. The main vessel is rewired through the stent struts, and after removal of the jailed wire, is dilated with a balloon to separate stent struts. The side branch wire is then removed (to prevent metal-to-metal jail) and the main vessel is stented covering the proximal and distal segment. The side-branch is re-wired and high pressure (e.g. 20 atm) individual inflations are made in each vessel at the bifurcation point to ensure good stent strut separation. Finally, a lower pressure kissing inflation is made.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DK-Crush Technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Both vessels have to be wired first. Lesion preparation in the main vessel and side branch may be undertaken according to operator preference (rotablation, if needed). After lesion preparation, the side branch is stented first. Side branch stent should have a small protrusion into the main branch. Before stent implantation in the side branch, an adequately sized balloon should be placed in the main branch, just opposite to the side branch ostium. After stent implantation in the side branch, stent balloon and wire are removed and the balloon in the main branch must be inflated, to crush the struts into the vessel wall. In next step, the new wire should be crossed into the ostium of the side branch and first kissing balloon dilatation will follow. The next step is to implant the second stent into the main branch, followed by a second kissing balloon-dilatation and final proximal optimisation (POT) procedure (single balloon inflation in proximal segment).</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stenting</intervention_name>
    <description>Comparison of two technical approaches in the interventional treatment on de-novo non-left main coronary lesions</description>
    <arm_group_label>Culotte Technique</arm_group_label>
    <arm_group_label>DK-Crush Technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - 1. Clinical indication (symptoms, ischemia documented or patients with acute coronary
        syndromes (NSTEMI) for interventional treatment of the bifurcation lesion.

        2. Clinical indication to perform the double stenting as judged by the operator.

        3. De-novo non-left main coronary bifurcation lesions according to the Medina
        classification of a native coronary artery with a reference vessel diameter: main branch
        &gt;2,5 mm; side branch &gt;2,25 mm (the difference between vessel diameter of the main and side
        branch should be ≤1 mm)

          -  Target lesion (main branch and / or side branch) with at least 50% diameter stenosis
             or fractional flow reserve (FFR) &lt; 0.80.

          -  The target lesion has not been previously treated with any interventional procedure.

          -  The target vessel (main branch and side branch) must be feasible for stent
             implantation (successful passage with the guide wire; successful pre-dilatation with
             an appropriately sized balloon; lesion preparation, if needed

          -  Patient has no other treatment planned within 30 days of the procedure.

          -  Patient has been informed of the nature of the study and agrees to its provisions and
             has written informed consent as approved by the Ethics Committee.

          -  Patient is willing to comply all required post-procedure follow-up.

        Exclusion Criteria:

          -  1. Patient had an acute myocardial infarction (&gt; 3x normal creatine kinase (CK))
             within 72 hours preceding the index procedure and CK has not returned to normal limits
             at the time of the procedure.

             2. Patient with a known hypersensitivity or contraindication to aspirin, heparin,
             clopidogrel, prasugrel, ticagrelor, stainless steel, everolimus or contrast media that
             cannot be adequately pre-medicated.

             3. Non successful treatment of other lesion during the same procedure

             4. Patient with a platelet count of &lt;100,000 cells/mm³ or &gt;700,000 cells/mm³, white
             blood cells of &lt;3,000 cells/mm³, or documented or liver disease.

             5. Patient with a history of bleeding diathesis or coagulopathy.

             6. Patient has suffered a stroke within the past six months.

             7. Active peptic ulcer or upper gastrointestinal bleeding within the prior 6 months.

             8. Patient has a co-morbidity (i.e. cancer or congestive heart failure) that may cause
             the patient to be non-compliant with the protocol, or is associated with limited
             life-expectancy (less than 2 years).

             9. Patient must be excluded from the study if any of these angiographic criteria are
             met:

               1. The target vessel contains intraluminal thrombus.

               2. The patient has undergone previous PCI to the target vessel within 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Heart Center Freiburg • Bad Krozingen</name>
      <address>
        <city>Bad Krozingen</city>
        <state>Suedring 15</state>
        <zip>79189</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miroslaw Ferenc, Dr.</last_name>
      <phone>0049 7633 4020</phone>
      <email>Miroslaw.Ferenc@universitaets-herzzentrum.de</email>
    </contact>
    <contact_backup>
      <last_name>Franz-Josef Neumann, Prof. Dr.</last_name>
      <phone>0049 7633 4020</phone>
      <email>Franz-Josef.Neumann@universitaets-herzzentrum.de</email>
    </contact_backup>
    <investigator>
      <last_name>Miroslaw Ferenc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Ferenc M, Gick M, Comberg T, Rothe J, Valina C, Toma A, Löffelhardt N, Hochholzer W, Riede F, Kienzle RP, Achtari A, Neumann FJ. Culotte stenting vs. TAP stenting for treatment of de-novo coronary bifurcation lesions with the need for side-branch stenting: the Bifurcations Bad Krozingen (BBK) II angiographic trial. Eur Heart J. 2016 Dec 1;37(45):3399-3405. doi: 10.1093/eurheartj/ehw345. Epub 2016 Aug 30.</citation>
    <PMID>27578807</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen SL, Xu B, Han YL, Sheiban I, Zhang JJ, Ye F, Kwan TW, Paiboon C, Zhou YJ, Lv SZ, Dangas GD, Xu YW, Wen SY, Hong L, Zhang RY, Wang HC, Jiang TM, Wang Y, Sansoto T, Chen F, Yuan ZY, Li WM, Leon MB. Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions: The 3-Year Follow-Up Results of the DKCRUSH-III Study. JACC Cardiovasc Interv. 2015 Aug 24;8(10):1335-42. doi: 10.1016/j.jcin.2015.05.017.</citation>
    <PMID>26315736</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen SL, Zhang JJ, Ye F, Chen YD, Lü SZ, Tan H, Patel T, Kenji K, Tamari I, Shan SJ, Zhu ZS, Lin S, Tian NL, Li XB, Liu ZZ, Lee M, Wei M, Xu YW, Yuan ZB, Qian J, Sun XW, Yang S, Chen JG, He B, Sumit S. [Comparison of DK crush with classical crush technique with drug-eluting stents for the treatment of coronary bifurcation lesions from DKCRUSH-1 study]. Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Feb;36(2):100-7. Chinese.</citation>
    <PMID>19099943</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen SL, Santoso T, Zhang JJ, Ye F, Xu YW, Fu Q, Kan J, Paiboon C, Zhou Y, Ding SQ, Kwan TW. A randomized clinical study comparing double kissing crush with provisional stenting for treatment of coronary bifurcation lesions: results from the DKCRUSH-II (Double Kissing Crush versus Provisional Stenting Technique for Treatment of Coronary Bifurcation Lesions) trial. J Am Coll Cardiol. 2011 Feb 22;57(8):914-20. doi: 10.1016/j.jacc.2010.10.023.</citation>
    <PMID>21329837</PMID>
  </results_reference>
  <results_reference>
    <citation>Erglis A, Kumsars I, Niemelä M, Kervinen K, Maeng M, Lassen JF, Gunnes P, Stavnes S, Jensen JS, Galløe A, Narbute I, Sondore D, Mäkikallio T, Ylitalo K, Christiansen EH, Ravkilde J, Steigen TK, Mannsverk J, Thayssen P, Hansen KN, Syvänne M, Helqvist S, Kjell N, Wiseth R, Aarøe J, Puhakka M, Thuesen L; Nordic PCI Study Group. Randomized comparison of coronary bifurcation stenting with the crush versus the culotte technique using sirolimus eluting stents: the Nordic stent technique study. Circ Cardiovasc Interv. 2009 Feb;2(1):27-34. doi: 10.1161/CIRCINTERVENTIONS.108.804658. Epub 2009 Feb 10.</citation>
    <PMID>20031690</PMID>
  </results_reference>
  <results_reference>
    <citation>Ferenc M, Buettner HJ, Gick M, Comberg T, Rothe J, Khoury F, Valina C, Toma A, Kuebler P, Riede F, Neumann FJ. Clinical outcome after percutaneous treatment of de novo coronary bifurcation lesions using first or second generation of drug-eluting stents. Clin Res Cardiol. 2016 Mar;105(3):230-8. doi: 10.1007/s00392-015-0911-7. Epub 2015 Sep 2.</citation>
    <PMID>26329585</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee JM, Hahn JY, Kang J, Park KW, Chun WJ, Rha SW, Yu CW, Jeong JO, Jeong MH, Yoon JH, Jang Y, Tahk SJ, Gwon HC, Koo BK, Kim HS. Differential Prognostic Effect Between First- and Second-Generation Drug-Eluting Stents in Coronary Bifurcation Lesions: Patient-Level Analysis of the Korean Bifurcation Pooled Cohorts. JACC Cardiovasc Interv. 2015 Aug 24;8(10):1318-31. doi: 10.1016/j.jcin.2015.05.014.</citation>
    <PMID>26315734</PMID>
  </results_reference>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>November 27, 2019</study_first_submitted>
  <study_first_submitted_qc>December 9, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2019</study_first_posted>
  <last_update_submitted>December 19, 2019</last_update_submitted>
  <last_update_submitted_qc>December 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Heart Center Freiburg - Bad Krozingen</investigator_affiliation>
    <investigator_full_name>Dr. Miroslaw FERENC</investigator_full_name>
    <investigator_title>Director of interventional cardiology department</investigator_title>
  </responsible_party>
  <keyword>PCI</keyword>
  <keyword>stent</keyword>
  <keyword>bifurcation</keyword>
  <keyword>Culotte</keyword>
  <keyword>DK-Crush</keyword>
  <keyword>restenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Stenosis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 20, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT04192760/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>December 9, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/60/NCT04192760/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

